Form 4: Belden EVP Granted 3,718 Restricted Stock Units
Executive Equity Grant
Belden Inc.'s EVP and Chief Innovation Officer, Hiran Bhadra, was granted 3,718 restricted stock units with a multi-year vesting schedule.
Summary
- Hiran Bhadra, EVP Chief Innovation Officer of Belden Inc., was granted 3,718 Restricted Stock Units (RSUs).
- The RSUs were granted by the Company's Compensation Committee on February 25, 2026.
- The vesting schedule for these RSUs is 25% on February 25, 2027, 25% on February 25, 2028, and 50% on February 25, 2029.
- Additional terms apply in the event of termination, death, disability, or retirement.
- Following this transaction, Bhadra directly holds 29,410 shares of common stock.
- Bhadra also indirectly holds 735.5246 shares of Belden Inc. common stock in the Belden Retirement Savings Plan.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive development, reflecting ongoing executive incentive alignment and retention efforts, which are generally favorable for corporate stability and long-term strategy execution.
Positives
- Grant of 3,718 Restricted Stock Units (RSUs) to a key executive, Hiran Bhadra, aligns management incentives with shareholder interests.
- The multi-year vesting schedule encourages long-term commitment and performance from the Chief Innovation Officer.
Future Outlook
The granted Restricted Stock Units will vest in tranches on February 25, 2027, February 25, 2028, and February 25, 2029, subject to continued employment and other terms.
Industry Context
StockSavvy.ai notes that equity grants like RSUs are a common component of executive compensation packages across various industries, particularly in technology and manufacturing sectors, to incentivize long-term performance and retention. This grant to the Chief Innovation Officer suggests Belden Inc. is focused on retaining key talent in strategic roles.
Comparison to Industry Standards
- Equity grants to executives are standard practice. Without specific details on Belden's compensation philosophy or peer group data, a direct comparison of the size of this grant (3,718 RSUs) to industry benchmarks or comparable companies like CommScope, Corning, or TE Connectivity is not feasible from this filing alone. However, the multi-year vesting schedule is typical for such awards.
Related Party Transactions
- Grant of 3,718 Restricted Stock Units to EVP Hiran Bhadra as part of executive compensation.
Stakeholder Impact
- Shareholders: The RSU grant aligns the executive's interests with long-term shareholder value creation, as the value of the RSUs is tied to the company's stock performance. It also represents potential future dilution upon vesting, though typically accounted for in compensation planning.
- Employees: No direct impact on general employees is indicated, but it signals the company's approach to executive incentives and retention.
Next Steps
- Vesting of 25% of RSUs on February 25, 2027.
- Vesting of 25% of RSUs on February 25, 2028.
- Vesting of 50% of RSUs on February 25, 2029.
Key Dates
| Date | Description |
|---|---|
| 03/11/2025 | Date Hiran Bhadra executed the Limited Power of Attorney for SEC reporting purposes. |
| 02/25/2026 | Date of RSU grant by the Company's Compensation Committee. |
| 02/27/2026 | Date the Form 4 was signed and filed. |
| 02/25/2027 | First vesting date for 25% of the granted RSUs. |
| 02/25/2028 | Second vesting date for 25% of the granted RSUs. |
| 02/25/2029 | Third vesting date for 50% of the granted RSUs. |
Recommendation
holdThis Form 4 filing details a routine executive equity grant and does not provide sufficient information to alter a broader investment thesis for Belden Inc. It indicates standard compensation practices and executive retention, which are generally neutral to slightly positive for long-term stability but not a catalyst for immediate price movement. Investors should continue to hold and monitor broader company performance and market conditions.
Keywords
Belden Inc., BDC, Hiran Bhadra, Restricted Stock Units, RSU grant, executive compensation, insider transaction, Form 4, equity award, Chief Innovation Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.